PAIP2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.250600E-01
Normal-vs-Stage2
7.124600E-03
Normal-vs-Stage3
9.334400E-01
Normal-vs-Stage4
4.348600E-01
Stage1-vs-Stage2
9.853000E-01
Stage1-vs-Stage3
8.668200E-01
Stage1-vs-Stage4
9.947000E-01
Stage2-vs-Stage3
8.789600E-01
Stage2-vs-Stage4
9.928400E-01
Stage3-vs-Stage4
8.816000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.808400E-01
Normal-vs-AfricanAmerican
5.933800E-01
Normal-vs-Asian
4.29889999999933E-05
Caucasian-vs-AfricanAmerican
9.343800E-01
Caucasian-vs-Asian
3.797100E-03
AfricanAmerican-vs-Asian
4.833900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.921100E-03
Normal-vs-Female
3.173600E-01
Male-vs-Female
1.309250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.784200E-01
Normal-vs-Age(41-60Yrs)
7.625400E-01
Normal-vs-Age(61-80Yrs)
4.983800E-01
Normal-vs-Age(81-100Yrs)
9.763000E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.989800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.770800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.959170E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.713400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.447630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.974400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.281600E-01
Normal-vs-Daily Drinker
4.760400E-01
Normal-vs-Weekly Drinker
1.535540E-02
Normal-vs-Occasional Drinker
4.509000E-01
Normal-vs-Social Drinker
4.806400E-01
Non Drinker-vs-Daily Drinker
6.866000E-01
Non Drinker-vs-Weekly Drinker
1.326790E-01
Non Drinker-vs-Occasional Drinker
4.410200E-01
Non Drinker-vs-Social Drinker
4.641000E-01
Daily Drinker-vs-Weekly Drinker
2.741200E-01
Daily Drinker-vs-Occasional Drinker
4.095600E-01
Daily Drinker-vs-Social Drinker
4.029000E-01
Weekly Drinker-vs-Occasional Drinker
3.234600E-01
Weekly Drinker-vs-Social Drinker
2.506000E-01
Occasional Drinker-vs-Social Drinker
7.211600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.950200E-01
Normal-vs-Grade 2
5.820000E-01
Normal-vs-Grade 3
8.003200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.167800E-02
Grade 1-vs-Grade 3
9.988100E-02
Grade 1-vs-Grade 4
6.950200E-01
Grade 2-vs-Grade 3
3.511800E-01
Grade 2-vs-Grade 4
5.820000E-01
Grade 3-vs-Grade 4
8.003200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.518800E-01
Normal-vs-NonDiabetic
7.173200E-01
Diabetic-vs-NonDiabetic
5.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.58746999999737E-05
Normal-vs-NoPancreatitis
6.084800E-01
Pancreatitis-vs-NoPancreatitis
1.512400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.214800E-01
Normal-vs-N1
9.898100E-02
N0-vs-N1
3.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.592400E-01
Normal-vs-TP53-NonMutant
1.182160E-01
TP53-Mutant-vs-TP53-NonMutant
2.257800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
